nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Complement—here, there and everywhere, but what about the transplanted organ?
|
Montero, R.M. |
|
2016 |
28 |
3 |
p. 250-259 10 p. |
artikel |
2 |
Complement inhibition in biomaterial- and biosurface-induced thromboinflammation
|
Ekdahl, Kristina N. |
|
2016 |
28 |
3 |
p. 268-277 10 p. |
artikel |
3 |
Complement inhibition in C3 glomerulopathy
|
Nester, Carla M. |
|
2016 |
28 |
3 |
p. 241-249 9 p. |
artikel |
4 |
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application
|
Hajishengallis, George |
|
2016 |
28 |
3 |
p. 285-291 7 p. |
artikel |
5 |
Complement therapeutics
|
Ricklin, Daniel |
|
2016 |
28 |
3 |
p. 205-207 3 p. |
artikel |
6 |
Complement therapeutic strategies in trauma, hemorrhagic shock and systemic inflammation – closing Pandora’s box?
|
Huber-Lang, Markus |
|
2016 |
28 |
3 |
p. 278-284 7 p. |
artikel |
7 |
Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies
|
Taylor, Ronald P. |
|
2016 |
28 |
3 |
p. 309-316 8 p. |
artikel |
8 |
New milestones ahead in complement-targeted therapy
|
Ricklin, Daniel |
|
2016 |
28 |
3 |
p. 208-222 15 p. |
artikel |
9 |
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities
|
Holers, V. Michael |
|
2016 |
28 |
3 |
p. 260-267 8 p. |
artikel |
10 |
Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future
|
Risitano, Antonio M. |
|
2016 |
28 |
3 |
p. 223-240 18 p. |
artikel |
11 |
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions
|
Brennan, Faith H. |
|
2016 |
28 |
3 |
p. 292-308 17 p. |
artikel |